Skip to content

Clinical trials

Breast Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Country / region: Netherlands Clear all

363 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20015
20024
20038
200410
20054
200613
200713
200816
20095
201017
201114
201217
201317
201422
201524
201612
201718
201811
201915
202013
202119
202215
202320
202418
202518
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed199
Recruiting57
Active, not recruiting37
Unknown status30
Terminated30
Withdrawn4
Not yet recruiting2
Enrolling by invitation2
Suspended1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Netherlands Cancer Institute40
Novartis Pharmaceuticals29
University Medical Center Groningen26
Maastricht University Medical Center23
European Organisation for Research and Treatment of Cancer - EORTC18
UMC Utrecht18
Hoffmann-La Roche16
Radboud University Medical Center15
AstraZeneca14
Amsterdam UMC, location VUmc9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms363
Neoplasm Metastasis30
Neoplasms26
Ovarian Neoplasms22
Lung Neoplasms16
Endometrial Neoplasms12
Stomach Neoplasms12
Carcinoma, Non-Small-Cell Lung11
Head and Neck Neoplasms10
Prostatic Neoplasms10

Trials

Showing 1 to 25 of 363. Each trial links to its page on Pharma Observatory.

263 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.